Learn More
Genscript Corporation SARS-CoV-2 Neutralizing Antibo
Supplier: Genscript Corporation A02088100
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain The product can recognize and neutralize Wild-Type SARS-CoV-2 and Variants of Concern (VOC) including Alpha Beta Delta and Omicron Reactivity with Gamma variant has not been tested
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.